Results 121 to 130 of about 2,075,366 (204)

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial [PDF]

BACKGROUND: Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive disease caused by the deposition of transthyretin as amyloid in the myocardium.
Alexander, Kevin M, Engelmann, Mads DM, Fontana, Marianna, Garcia-Pavia, Pablo, Grogan, Martha, Hovingh, G Kees, Kar, Soumitra, Kristen, Arnt V, Lim-Watson, Michelle, Malling, Brian, Maurer, Mathew S, Revanna, Manjunatha, Sarswat, Nitasha, Shah, Sanjiv J, Tsujita, Kenichi   +14 more
core  

Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis. [PDF]

BMJ Open
Gröschel J, Barzen G, Zernikow J, Blaszczyk E, Hahn K, Pernice HF, Sack I, Romero Dorta E, van Dijck P, Heidecker B, Schwenke C, Schulz-Menger J, Spethmann S.   +12 more
europepmc   +1 more source

The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): A plain language summary. [PDF]

Future Cardiol
Grogan M, Davis MK, Crespo Leiro MG, Sultan MB, Gundapaneni B, Angeli FS, Hanna M.   +6 more
europepmc   +1 more source

Multiple Red Flags of Transthyretin Amyloid Cardiomyopathy in a Single Patient: A Case Report on Diagnostic Challenge. [PDF]

Int Med Case Rep J
Yao L, Chen K, Zhang F, Qin J.
europepmc   +1 more source

Dynamic Acquisition of [^99mTc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study. [PDF]

J Nucl Med
Auer B, De Moraes A, Pabon AJR, Clerc OF, Bhimaniya S, Kijewski MF, Kurian A, Vijayakumar S, Cuddy SAM, Di Carli MF, Dorbala S.   +10 more
europepmc   +1 more source

Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Heart Fail
Lu R, Nalbandian A, Akita K, Teruya S, Bampatsias D, Santos AM, Maurer MS, Shimada YJ.   +7 more
europepmc   +1 more source

Endomyocardial Biopsy Revisited: Diagnostic Value and Expanding Roles in Cardiac Amyloidosis. [PDF]

Curr Heart Fail Rep
Schwarting SK, Aus dem Siepen F.
europepmc   +1 more source

Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study. [PDF]

Front Nucl Med
Tingen HSA, Stormezand GN, van Snick P, Hu Y, Van Der Zwaag P, Oerlemans M, van der Meer P, Hazenberg BPC, Luurtsema G, Nienhuis HLA, Slart RHJA.   +10 more
europepmc   +1 more source

Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM. [PDF]

Future Cardiol
Sarswat N, Ambardekar AV, Alexander KM, Cuddy SA, Stern L, Poulsen SH, Tschöpe C, Sekijima Y, Sheikh FH, Griffin JM, Judge DP, Gillmore J, Masri A.   +12 more
europepmc   +1 more source